Currently, there are 448.51M common shares owned by the public and among those 447.43M shares have been available to trade.
The company’s stock has a 5-day price change of 1.35% and 13.76% over the past three months. NI shares are trading 24.52% year to date (YTD), with the 12-month market performance up to 23.59% higher. It has a 12-month low price of $22.86 and touched a high of $33.10 over the same period. NI has an average intraday trading volume of 4.17 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.56%, 7.85%, and 18.57% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of NiSource Inc (NYSE: NI) shares accounts for 99.49% of the company’s 448.51M shares outstanding.
It has a market capitalization of $14.83B and a beta (3y monthly) value of 0.50. The stock’s trailing 12-month PE ratio is 20.28, while the earnings-per-share (ttm) stands at $1.63. The company has a PEG of 2.70 and a Quick Ratio of 0.63 with the debt-to-equity ratio at 1.71. Price movements for the stock have been influenced by the stock’s volatility, which stands at 0.99% over the week and 1.45% over the month.
Earnings per share for the fiscal year are expected to increase by 8.05%, and 6.68% over the next financial year.
Looking at the support for the NI, a number of firms have released research notes about the stock. Mizuho stated their Outperform rating for the stock in a research note on July 11, 2024, with the firm’s price target at $33. Barclays coverage for the NiSource Inc (NI) stock in a research note released on January 22, 2024 offered a Overweight rating with a price target of $28. Ladenburg Thalmann was of a view on October 06, 2023 that the stock is Buy, while UBS gave the stock Buy rating on June 06, 2023, issuing a price target of $31. Credit Suisse on their part issued Outperform rating on November 09, 2022.
